| |
|
|
|
GeneExpression Systems, Inc., Doubletree Guest Suites, 550 Winter Street,, Waltham, MA, 02451 USA
May 01-03, 2006
"RNA interference: Biochemical Genetics to Drugs & Therapeutics”The most-up-to-date developments will be addressed:
• The Biochemical Genetics of RNAi and microRNAs
• RNAi Biochemistry and Mechanisms in various organisms
• New vectors for RNAi delivery in vivo, in vitro
• microRNAs discovery and their diverse roles in biology
• Computational and Disease Biology of miRNAs
• Drug Target identification and Validation
• High throughput genome-wide screenings
• Innovative strategies to develop anti-viral, ocular and cancer therapeutics Target audience:
Executives, Directors and Scientists of R&D from biotech and pharmaceuticals.
Graduate students, Post-docs, and Professors from Academia.
Investors, Thought leaders and Business Development people in life sciences who need to know
the emerging technologies.
|
|
|
|
|
|
|
|
Organized by:
|
|
GeneExpression Systems, Inc. |
|
|
Invited Speakers:
|
|
“A Unique Meeting Completely Dedicated to RNAi and its Applications” Meeting Description:
Nobel laureate Richard Roberts (New England Biolabs)
Eminent Biochemical Geneticist of the century Earl Stadtman (NIH)
Gene suppression innovator Richard Jorgensen (Univ. of Arizona) and authorities in the RNAi field including: Frank Slack (Yale), Ulrike Gaul (Rockefeller), Marc Vidal and Andre Verdel (Harvard), Kuan-The Jeang (NIH), Olivier Voinnet (CNRS, France), Antonio Giraldez (NYU), Young-sik Lee (Northwestern), Tariq Rana (UMass), Ihor Lemischka (Princeton), Don Ganem (UCSF), Andrea Ventura (MIT), Ramin Shiekhattar (Wistar Inst), and several biotech and pharmaceutical Communities will be speaking on the biology of RNAi and their utilizations in Target validation, drug and therapeutic development.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
March 20, 2006
|
|
|
|
|
|
|
|
Registration:
|
|
Academia: US$ 699
Industry: US$1099
|
|
|
E-mail:
|
|
Genexpsys@expressgenes.com
|
|
|
|
|
|
|
|
|